255 related articles for article (PubMed ID: 23441207)
1. Osteoblast-targeted overexpression of TAZ increases bone mass in vivo.
Yang JY; Cho SW; An JH; Jung JY; Kim SW; Kim SY; Kim JE; Shin CS
PLoS One; 2013; 8(2):e56585. PubMed ID: 23441207
[TBL] [Abstract][Full Text] [Related]
2. Osteoblast-targeted overexpression of PPARγ inhibited bone mass gain in male mice and accelerated ovariectomy-induced bone loss in female mice.
Cho SW; Yang JY; Her SJ; Choi HJ; Jung JY; Sun HJ; An JH; Cho HY; Kim SW; Park KS; Kim SY; Baek WY; Kim JE; Yim M; Shin CS
J Bone Miner Res; 2011 Aug; 26(8):1939-52. PubMed ID: 21351141
[TBL] [Abstract][Full Text] [Related]
3. TM-25659 enhances osteogenic differentiation and suppresses adipogenic differentiation by modulating the transcriptional co-activator TAZ.
Jang EJ; Jeong H; Kang JO; Kim NJ; Kim MS; Choi SH; Yoo SE; Hong JH; Bae MA; Hwang ES
Br J Pharmacol; 2012 Mar; 165(5):1584-94. PubMed ID: 21913895
[TBL] [Abstract][Full Text] [Related]
4. Deficiency of Macf1 in osterix expressing cells decreases bone formation by Bmp2/Smad/Runx2 pathway.
Qiu WX; Ma XL; Lin X; Zhao F; Li DJ; Chen ZH; Zhang KW; Zhang R; Wang P; Xiao YY; Miao ZP; Dang K; Wu XY; Qian AR
J Cell Mol Med; 2020 Jan; 24(1):317-327. PubMed ID: 31709715
[TBL] [Abstract][Full Text] [Related]
5. Osteoblast-Specific Overexpression of Human WNT16 Increases Both Cortical and Trabecular Bone Mass and Structure in Mice.
Alam I; Alkhouli M; Gerard-O'Riley RL; Wright WB; Acton D; Gray AK; Patel B; Reilly AM; Lim KE; Robling AG; Econs MJ
Endocrinology; 2016 Feb; 157(2):722-36. PubMed ID: 26584014
[TBL] [Abstract][Full Text] [Related]
6. (-)-Epicatechin gallate (ECG) stimulates osteoblast differentiation via Runt-related transcription factor 2 (RUNX2) and transcriptional coactivator with PDZ-binding motif (TAZ)-mediated transcriptional activation.
Byun MR; Sung MK; Kim AR; Lee CH; Jang EJ; Jeong MG; Noh M; Hwang ES; Hong JH
J Biol Chem; 2014 Apr; 289(14):9926-35. PubMed ID: 24515112
[TBL] [Abstract][Full Text] [Related]
7. FGF2 stimulates osteogenic differentiation through ERK induced TAZ expression.
Byun MR; Kim AR; Hwang JH; Kim KM; Hwang ES; Hong JH
Bone; 2014 Jan; 58():72-80. PubMed ID: 24125755
[TBL] [Abstract][Full Text] [Related]
8. Mitogen-activated protein kinase phosphatase 1 regulates bone mass, osteoblast gene expression, and responsiveness to parathyroid hormone.
Mahalingam CD; Datta T; Patil RV; Kreider J; Bonfil RD; Kirkwood KL; Goldstein SA; Abou-Samra AB; Datta NS
J Endocrinol; 2011 Nov; 211(2):145-56. PubMed ID: 21852324
[TBL] [Abstract][Full Text] [Related]
9. Transforming growth factor beta1 induces osteogenic differentiation of murine bone marrow stromal cells.
Zhao L; Jiang S; Hantash BM
Tissue Eng Part A; 2010 Feb; 16(2):725-33. PubMed ID: 19769530
[TBL] [Abstract][Full Text] [Related]
10. Osteoblastogenic effects of dexamethasone through upregulation of TAZ expression in rat mesenchymal stem cells.
Hong D; Chen HX; Xue Y; Li DM; Wan XC; Ge R; Li JC
J Steroid Biochem Mol Biol; 2009 Aug; 116(1-2):86-92. PubMed ID: 19460432
[TBL] [Abstract][Full Text] [Related]
11. Ephrin B1 regulates bone marrow stromal cell differentiation and bone formation by influencing TAZ transactivation via complex formation with NHERF1.
Xing W; Kim J; Wergedal J; Chen ST; Mohan S
Mol Cell Biol; 2010 Feb; 30(3):711-21. PubMed ID: 19995908
[TBL] [Abstract][Full Text] [Related]
12. BMP signaling is required for RUNX2-dependent induction of the osteoblast phenotype.
Phimphilai M; Zhao Z; Boules H; Roca H; Franceschi RT
J Bone Miner Res; 2006 Apr; 21(4):637-46. PubMed ID: 16598384
[TBL] [Abstract][Full Text] [Related]
13. Osteoblast menin regulates bone mass in vivo.
Kanazawa I; Canaff L; Abi Rafeh J; Angrula A; Li J; Riddle RC; Boraschi-Diaz I; Komarova SV; Clemens TL; Murshed M; Hendy GN
J Biol Chem; 2015 Feb; 290(7):3910-24. PubMed ID: 25538250
[TBL] [Abstract][Full Text] [Related]
14. Targeted overexpression of G protein-coupled receptor kinase-2 in osteoblasts promotes bone loss.
Wang L; Liu S; Quarles LD; Spurney RF
Am J Physiol Endocrinol Metab; 2005 Apr; 288(4):E826-34. PubMed ID: 15585587
[TBL] [Abstract][Full Text] [Related]
15. The YAP/TAZ transcriptional co-activators have opposing effects at different stages of osteoblast differentiation.
Xiong J; Almeida M; O'Brien CA
Bone; 2018 Jul; 112():1-9. PubMed ID: 29626544
[TBL] [Abstract][Full Text] [Related]
16. Transgenic Expression of Osteoactivin/gpnmb Enhances Bone Formation In Vivo and Osteoprogenitor Differentiation Ex Vivo.
Frara N; Abdelmagid SM; Sondag GR; Moussa FM; Yingling VR; Owen TA; Popoff SN; Barbe MF; Safadi FF
J Cell Physiol; 2016 Jan; 231(1):72-83. PubMed ID: 25899717
[TBL] [Abstract][Full Text] [Related]
17. Bone vs. fat: embryonic origin of progenitors determines response to androgen in adipocytes and osteoblasts.
Wiren KM; Hashimoto JG; Semirale AA; Zhang XW
Bone; 2011 Oct; 49(4):662-72. PubMed ID: 21704206
[TBL] [Abstract][Full Text] [Related]
18. The Transcriptional Modulator Interferon-Related Developmental Regulator 1 in Osteoblasts Suppresses Bone Formation and Promotes Bone Resorption.
Iezaki T; Onishi Y; Ozaki K; Fukasawa K; Takahata Y; Nakamura Y; Fujikawa K; Takarada T; Yoneda Y; Yamashita Y; Shioi G; Hinoi E
J Bone Miner Res; 2016 Mar; 31(3):573-84. PubMed ID: 26391411
[TBL] [Abstract][Full Text] [Related]
19. Effect of osteoblast-targeted expression of bcl-2 in bone: differential response in male and female mice.
Pantschenko AG; Zhang W; Nahounou M; McCarthy MB; Stover ML; Lichtler AC; Clark SH; Gronowicz GA
J Bone Miner Res; 2005 Aug; 20(8):1414-29. PubMed ID: 16007339
[TBL] [Abstract][Full Text] [Related]
20. TAZ is required for the osteogenic and anti-adipogenic activities of kaempferol.
Byun MR; Jeong H; Bae SJ; Kim AR; Hwang ES; Hong JH
Bone; 2012 Jan; 50(1):364-72. PubMed ID: 22108137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
